Насонова Т.И., Романов Д.В., Исайкин А.И. Вопросы эффективного лечения фибромиалгии. Клинический случай. Consilium Medicum. 2021;23(11):874–878. DOI: 10.26442/20751753.2021.11.201142
________________________________________________
Nasonova TI, Romanov DV, Isaykin AI. Questions of effective treatment of fibromyalgia. Case report. Consilium Medicum. 2021;23(11):874–878. DOI: 10.26442/20751753.2021.11.201142
Вопросы эффективного лечения фибромиалгии
Насонова Т.И., Романов Д.В., Исайкин А.И. Вопросы эффективного лечения фибромиалгии. Клинический случай. Consilium Medicum. 2021;23(11):874–878. DOI: 10.26442/20751753.2021.11.201142
________________________________________________
Nasonova TI, Romanov DV, Isaykin AI. Questions of effective treatment of fibromyalgia. Case report. Consilium Medicum. 2021;23(11):874–878. DOI: 10.26442/20751753.2021.11.201142
Представлен клинический случай эффективного лечения фибромиалгии у пациентки 58 лет междисциплинарной командой неврологов и психиатра-психотерапевта. В течение 5 лет до госпитализации в Клинику нервных болезней ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет) у пациентки, страдающей распространенной хронической болью в спине и конечностях, не установлен диагноз фибромиалгии, она проходила многочисленные дорогостоящие обследования и различные методы терапии, которые оказывались неэффективными, что ухудшало ее состояние и усиливало интенсивность болевого синдрома. Установление фибромиалгии, выявление сопутствующих психических расстройств позволило использовать фармакотерапию и нефармакологические методы лечения (когнитивно-поведенческая терапия, кинезиотерапия), которые привели к стойкому улучшению состояния, уменьшению болевого синдрома в течение 6 мес последующего наблюдения.
Ключевые слова: фибромиалгия, фармакологические и нефармакологические методы лечения фибромиалгии, диагностические критерии
________________________________________________
A clinical case of effective treatment of fibromyalgia in a 58-year-old patient by an interdisciplinary team of neurologists and a psychiatrist-psychotherapist is presented. For 5 years before being hospitalized at the Sechenov First Moscow State Medical University (Sechenov University) Clinic of Nervous System Diseases, a patient suffering from widespread chronic pain in the back and extremities was not diagnosed with fibromyalgia, she underwent numerous expensive examinations and various methods of therapy that were not effective, worsened her condition and increased the intensity of the pain syndrome. The establishment of fibromyalgia, the identification of concomitant mental disorders, allowed the use of pharmacotherapy and non-pharmacological methods of treatment (cognitive behavioral therapy, kinesiotherapy), which led to a persistent improvement in the condition, a decrease in pain syndrome during 6 months of follow-up.
Keywords: fibromyalgia, pharmacological and non-pharmacological methods of treatment of fibromyalgia, diagnostic criteria
1. Sarzi-Puttini P, Giorgi V, Atzeni F, et al. Fibromyalgia position paper. Clin Exp Rheumatol. 2021;39(3):186-93.
2. Baillou G. Liber de Rheumatismo et Pleuritide Dorsali. Thevart MJ. 1642.
3. Gowers WR. The development of the concept of fibrositis. Br Med J. 1904;1:117-21.
4. Boland EW. Psychogenic rheumatism: The musculoskeletal expression of psychoneurosis. Ann Rheum Dis. 1947;6(4):195-203.
5. Hench PK. Nonarticular rheumatism, 22nd rheumatism review: review of the American and English literature for the years 1973 and 1974. Arthritis Rheumatol. 1976;19:1081-9.
6. Smythe HA, Moldofsky H. Two contributions to understanding of the fibrositis syndrome. Bull Rheum Dis. 1977;28:928-31.
7. Arnold LM, Bennett RM, Crofford LJ, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20(6):611-28. DOI:10.1016/j.jpain.2018.10.008
8. Напрюшкина В.И., Долинская Ю.А., Дума С.Н., Рымар О.Д. Синдром фибромиалгии у пациентки с послеоперационным пангипопитуитаризмом. Клинический случай. Неврология Сибири. 2016;2(4):29-31 [Napryushkina VI, Dolinskaya YA, Duma SN, Rymar OD. Fibromyalgia syndrome in a patient with postoperative panhypopituitarism. Clinical case. Nevrologiya Sibiri. 2016;2(4):29-31 (in Russian)].
9. Walitt B, Klose P, Üçeyler N, et al. Antipsychotics for fibromyalgia in adults. Cochrane Database Syst Rev. 2016;2016(6):CD011804. DOI:10.1002/14651858.CD011804.pub2
10. Abramowitz JS, Braddock AE. Psychological treatment of health anxiety and hypochondriasis: a biopsychosocial approach. Hogrefe & Huber Publishers, 2008.
11. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356. DOI:10.1007/s11916-013-0356-5
12. McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21(3):403-25. DOI:10.1016/j.berh.2007.03.003
13. Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol. 1995;22(1):151-6.
14. Choy E, Perrot S, Leon T, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010;10:102. DOI:10.1186/1472-6963-10-102
15. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 citeria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-72. DOI:10.1002/art.1780330203
16. Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319-29. DOI:10.1016/j.semarthrit.2016.08.012
17. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-55. DOI:10.1001/jama.2014.3266
18. Häuser W, Petzke F, Üçeyler N, Sommer C. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford). 2011;50(3):532-43. DOI:10.1093/rheumatology/keq354
19. Cooper TE, Derry S, Wiffen PJ, Moore RA. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017;1(1):CD012188. DOI:10.1002/14651858.cd012188.pub2
20. Üçeyler N, Sommer C, Walitt B, Häuser W. Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2013;10:CD010782. DOI:10.1002/14651858.CD010782
21. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2016;76(2):318-28.
DOI:10.1136/annrheumdis-2016-209724
22. Bernardy K, Klose P, Busch AJ, et al. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;2013(9):CD009796. DOI:10.1002/14651858.CD009796.pub2
23. Давыдов О.С., Глебов М.В. Фибромиалгия. Рос. журн. боли. 2020;18(3):66-74 [Davydov OS, Glebov MV. Fibromyalgia. Russian Journal of Pain. 2020;18(3):66-74 (in Russian)].
DOI:10.17116/pain20201803166
24. Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27. DOI:10.1097/j.pain.0000000000001384
25. Чурюканов М.В., Загорулько О.И. Принципы и последовательность организации помощи пациентам с хронической неонкологической болью. Клин. и экспериментальная хирургия. Журн. им. акад. Б.В. Петровского. 2016;4(3):20-7 [Churyukanov MV, Zagorulko OI. Principles and sequence of medical care for patients with chronic non-cancer pain. Clinical and Experimental Surgery. Journal them. acad. BV Petrovsky. 2016;4(3):20-7 (in Russian)].
________________________________________________
1. Sarzi-Puttini P, Giorgi V, Atzeni F, et al. Fibromyalgia position paper. Clin Exp Rheumatol. 2021;39(3):186-93.
2. Baillou G. Liber de Rheumatismo et Pleuritide Dorsali. Thevart MJ. 1642.
3. Gowers WR. The development of the concept of fibrositis. Br Med J. 1904;1:117-21.
4. Boland EW. Psychogenic rheumatism: The musculoskeletal expression of psychoneurosis. Ann Rheum Dis. 1947;6(4):195-203.
5. Hench PK. Nonarticular rheumatism, 22nd rheumatism review: review of the American and English literature for the years 1973 and 1974. Arthritis Rheumatol. 1976;19:1081-9.
6. Smythe HA, Moldofsky H. Two contributions to understanding of the fibrositis syndrome. Bull Rheum Dis. 1977;28:928-31.
7. Arnold LM, Bennett RM, Crofford LJ, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20(6):611-28. DOI:10.1016/j.jpain.2018.10.008
8. Napryushkina VI, Dolinskaya YA, Duma SN, Rymar OD. Fibromyalgia syndrome in a patient with postoperative panhypopituitarism. Clinical case. Nevrologiya Sibiri. 2016;2(4):29-31 (in Russian).
9. Walitt B, Klose P, Üçeyler N, et al. Antipsychotics for fibromyalgia in adults. Cochrane Database Syst Rev. 2016;2016(6):CD011804. DOI:10.1002/14651858.CD011804.pub2
10. Abramowitz JS, Braddock AE. Psychological treatment of health anxiety and hypochondriasis: a biopsychosocial approach. Hogrefe & Huber Publishers, 2008.
11. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356. DOI:10.1007/s11916-013-0356-5
12. McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21(3):403-25. DOI:10.1016/j.berh.2007.03.003
13. Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol. 1995;22(1):151-6.
14. Choy E, Perrot S, Leon T, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010;10:102. DOI:10.1186/1472-6963-10-102
15. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 citeria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-72. DOI:10.1002/art.1780330203
16. Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319-29. DOI:10.1016/j.semarthrit.2016.08.012
17. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-55. DOI:10.1001/jama.2014.3266
18. Häuser W, Petzke F, Üçeyler N, Sommer C. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford). 2011;50(3):532-43. DOI:10.1093/rheumatology/keq354
19. Cooper TE, Derry S, Wiffen PJ, Moore RA. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017;1(1):CD012188. DOI:10.1002/14651858.cd012188.pub2
20. Üçeyler N, Sommer C, Walitt B, Häuser W. Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2013;10:CD010782. DOI:10.1002/14651858.CD010782
21. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2016;76(2):318-28.
DOI:10.1136/annrheumdis-2016-209724
22. Bernardy K, Klose P, Busch AJ, et al. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;2013(9):CD009796. DOI:10.1002/14651858.CD009796.pub2
23. Davydov OS, Glebov MV. Fibromyalgia. Russian Journal of Pain. 2020;18(3):66-74 (in Russian).
DOI:10.17116/pain20201803166
24. Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27. DOI:10.1097/j.pain.0000000000001384
25. Churyukanov MV, Zagorulko OI. Principles and sequence of medical care for patients with chronic non-cancer pain. Clinical and Experimental Surgery. Journal them. acad. BV Petrovsky. 2016;4(3):20-7 (in Russian).
Авторы
Т.И. Насонова*1, Д.В. Романов1,2, А.И. Исайкин1
1 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия;
2 ФГБНУ «Научный центр психического здоровья», Москва, Россия
*tatiana.martova@yandex.ru
________________________________________________
Tatiana I. Nasonova*1, Dmitry V. Romanov1,2, Alexey I. Isaykin1
1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
2 Mental Health Research Center, Moscow, Russia
*tatiana.martova@yandex.ru